dihydroxyphenylalanine has been researched along with Prostatic Hyperplasia in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agusta, VE | 1 |
| Gillenwater, JY | 1 |
| Mann, JD | 1 |
1 other study available for dihydroxyphenylalanine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Postoperative bleeding associated with levodopa therapy.
Topics: Aged; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dihydroxyphenylalanine; Hematocrit | 1973 |